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Summary
The technologies enabling the creation of large scale, miniaturized peptide or protein microarrays are emerging. The focuses
of this review are the synthesis and applications of peptide and peptidomimetic microarrays, especially the light directed
parallel synthesis of individually addressable high density peptide microarrays using a novel photogenerated reagent chemistry
and digital photolithography (Gao et al., 1998, J. Am. Chem. Soc. 120, 12698; Pellois et al. 2002, Nat. Biotechnol. 20,
922). Concepts related to the synthesis are discussed, such as the reactions of photogenerated acids in the deprotection step of
peptide synthesis or oligonucleotide synthesis, and the applications of high density peptide chips in antibody binding assays are
discussed. Peptide chips provide versatile tools for probing antigen-antibody, protein-protein, peptide-ligand interactions and
are basic components for miniaturization, automation, and system integration in research and clinical diagnosis applications.
Abbreviations: cm, centimeter; CPG, Controlled porous glass; DCM, dichloride methylene; DMT, 4,4’-dimethoxytrityl; Fmoc,
9-fluorenyl methoxycarbonyl; FR, fluorescein; ivDde, 4,4-dimethyl-2,6-dioxocyclohexylidene-)3-methyl-butyl; MeNPOC,
(α-methyl-2-nitropiperonyl)oxycarbonyl; mRNA, message RNA; NPPOC-Hz, 2-(2-nitrophenyl)propoxycarbonyl hydrazine;
NPPOC-pip, 2-(2-nitrophenyl)propoxycarbonyl piperidine; NVOC, nitroveratryloxycarbonyl; PGA, photogenerated acid;
PGA-P, photogenerated acid precursor; PGB, photogenerated base; PGB-P, photogenerated base precursors; PGR, photo-
generated reagents; PGR-P, photogenerated reagent precursor; PLPG, photo-labile protecting group; SPR, surface plasmon
resonance; t-Boc, ter-butyloxycarbonyl; TCA, trichloroacetic acid; TFA, trifluoroacetic acid.
Introduction
The idea and the practice of using a large amount of mo-
lecules to simultaneously probe intermolecular interactions
were first intensively pursued in the areas of peptides about
two decades ago [1–8]. But the relative ease of DNA
synthesis in a highly parallel fashion and the simplicity
of DNA chemistry, such as complementary hybridization
among nucleic acid sequences, have quickly led to wide-
spread applications of DNA microarrays [9, 10], which now
far outpace those of peptide microarrays. DNA chips have
validated the format of addressable microarrays as a means
of extremely efficient parallel data acquisition. When em-
powered with high speed data processing and statistical data
analysis [11], microarray results, such as those of gene
expression or single nucleotide polymorphism (SNP) ana-
lysis, offer insights into biological systems of individual and
global components at an unprecedented comprehensive and
detailed level [12–18].
Microarrays of protein [19–22], peptide or peptidomi-
metic molecules [23–35] are fundamentally different in their
chemistry and use. In particular, there are 20 natural amino
acids compared to only four natural DNA or RNA nucle-
otides. The chemistry of peptide synthesis is therefore much
more complicated. Peptides and proteins have multifaceted
properties, while nucleic acids are distinct in their backbone
of negative charges. The interactions of peptides or proteins
with other molecules are thus dominated with molecular
forces of different nature. The diverse chemical properties
of peptides and proteins permit their broad range of roles,
for instance, as receptors, fusion mediators, structural stabil-
izers, and regulatory factors, implicated in, e.g., signaling,
stimulation, catalysis, inhibition, and initiation of biolo-
gical processes. Peptide or protein microarrays should find
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Scheme 1. Illustration of the apllications of protein and peptide micro-
arrays.
key applications for therapeutic target identification, protein
function assay, drug discovery, and diagnostics (Scheme 1).
Accordingly the applications involving peptides and proteins
impose a number of requirements for the intended purposes
(Scheme 1). It is desirable to develop peptide and protein
microarrays that are easy to produce at minimal cost and
time consumption, flexible to suit a broad range of needs,
specific and sensitive for target detection, capable of large
dynamic range detection, reliable in reproducibility, and
stable under the conditions of assays and storage. To meet
these requirements, technologies enabling the creation of
useful peptide or protein microarrays are emerging. A num-
ber of reviews in this issue of the journal and elsewhere
have thoroughly summarized the major topics in the field
[19–22, 31–34]. The focuses of this review are the synthesis
and applications of peptide and peptidomimetic microarrays
(peptide microarrays), especially the light directed parallel
synthesis of individually addressable high density peptide
microarrays using a novel PGR chemistry [25, 36–41]. In
this review, the term peptide chip refers more specifically
to peptide microarrays of higher density (more than 1,000
features on a chip of about one square cm).
In situ synthesis of peptide microarrays
An overall review of peptide microarray synthesis
Both peptide microarrays and peptide libraries consist of a
large number of sequences. The major difference between
the two is that the specific sequence information can be ob-
tained through the location within peptide microarrays [3–8,
25–29, 31–35]. Peptide microarrays refer to a format of flat
surface on which peptide sequences are organized in rows
and columns, and in most cases, according to a predeter-
mined pattern. A peptide library is usually created by phage
display [42–45] or combinatorial synthesis in solution or
on certain types of supports, such as beads [3], based on
a split-and-mix [46] strategy possibly to give one bead one
compound (OBOC) [33]. Theis approach relies on special
ways of tagging/coding the beads to register structural in-
formation on a bead. In these settings, up to 1012 different
peptides (natural amino acids only for phage display) may
be screened; the binding experiments are followed by ‘de-
coding’ on beads, using sequencing, chemical tracking, or
other reading methods. The operations of such peptide lib-
rary synthesis and binding assays tend to be laborious and
time consuming. Recent developments in laboratory robots,
synthesis instruments, and tagging methods, such as the
direct sorting and radio frequency (RF) tracking instrument
by Irori, have greatly reduced manual operations required
[47]. In this process, milligram quantities of materials are
prepared which can then be dissolved and the solution spot-
ted onto a surface to form microarrays for screening assays
[48, 49].
Peptide microarrays are made by several methods, in-
cluding robotic deposition of pre-synthesized peptides [30],
panning phage display peptides onto a flat surface [34], or in
situ synthesis, which can be further divided into either direct
synthesis or parallel synthesis [6, 25, 31–35, 41]. One of
the clear advantages of peptide microarrays is that the bind-
ing results can be obtained immediately from the location
of a specific sequence. The density of the sequences on a
microarray ranges from a few to thousands in a square cm
area for arrays of minute size, such as the size of 1 × 3
microscope slides, called peptide chips. Peptide and pep-
tidomimetic microarrays made by synthetic methods should
complement random peptide libraries in their capability of
further refining the consensus binding sequences at a much
higher resolution by discriminating at the level of a single
amino acid and also expanding the sequence diversity due to
their ease for incorporating synthetic building blocks.
There are additional challenges for peptide synthesis
in a miniaturized format and scale. Unlike nucleotides of
DNA which have four natural monomers formed by the
same phosphorylated penta-saccharide and differing only
in their base moieties, there are 20 amino acids contain-
ing side chains linked with a variety of functional groups,
having different sizes or opposite polarities. Peptide solid
phase synthesis using t-Boc (ter-butyloxycarbonyl) or fmoc
(9-fluorenyl methoxycarbonyl) chemistry take much longer
time per cycle (∼ 2 h) and the stepwise yield (∼ 97–
98%) is not as ideal as oligonucleotide synthesis (> 98.5%)
[50]. Since parallel synthesis, especially in situ parallel syn-
thesis, is controlled by reaction cycles and, for instance, a
pentapeptide array synthesis including all 20 amino acids
would require 100 reaction cycles, a peptide chip synthesis
potentially can take a few days and sequences synthes-
ized are of moderate quality. Therefore, a useful synthesis
method for peptide microarrays needs to provide solutions
to overcome these barriers.
Direct synthesis on surface or in situ synthesis of micro-
arrays is seen as an effective means of miniaturization of
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traditional chemical reactions and assays. Several methods
have been reported for in situ synthesis of peptide micro-
arrays. A popular approach of direct synthesis on surface is
SPOT [5, 31, 34], which uses a robotic instrument to deliver
synthetic building blocks and reaction reagents, following
standard chemical reaction conditions, onto a filter paper or
a cellulose or nylon membrane sheet in an area of several
square inches, and the solvent washing steps are manual.
The SPOT peptide microarray is then incubated with the
sample and the assays require milliliters of the sample. This
method has gained wide acceptance to allow screening epi-
tope sequences, enzymatic reaction substrates, and protein
binding ligands at a low cost. SPOT synthesis also easily
incorporates modified or non-natural amino acid building
blocks, making possible the creation of diverse peptidomi-
metic sequences for binding assays. A recent application
illustrates SPOT synthesis of a pair of peptide sequences at
the same reaction site for the studies of protein-protein in-
teractions potentially involving multiple weak contacts [51].
The synthesis used both fmoc-alanine and alloc-alanine at
the first cycle to achieve selective deprotection and thus the
synthesis of a peptide containing a Ser residue as a model for
Elk-1 Ser383 phosphorylation by ERK-2 kinase and a pep-
tide representing the Elk-1-docking domain. The results of
the enzymatic experiments suggest that the Ser phosphoryla-
tion requires the presence of the Elk-1-docking domain. The
synergic effects of a pair of discontinuous peptides were also
observed for phosphatase activities of protein-tyrosine phos-
phatase (PTP) 1B on insulin receptor. Many examples shown
in the literature have validated the peptide microarray plat-
form as an effective tool for probing molecular recognition
and interactions; this represents significant technological
advancement for research in the fields of molecular immun-
ology, signal transduction, drug discovery, and molecular
diagnostics.
Another conceptually interesting method of in situ pep-
tide microarray synthesis for producing high density peptide
chips is light-directed parallel synthesis using nonconven-
tional photo-labile protected amino acids as building blocks
(Figure 1A) [6, 35]. The synthesis involves multi-cycles
(Figure 1B) with each cycle using light irradiation through a
photomask followed by adding one type of amino acid to
specific locations where the photo-labile protecting group
(PLPG) on the terminal of the growing chain has been re-
moved upon light irradiation. The amino acids used in the
synthesis are not conventional but protected at the amino
position with a PLPG, such as nitroveratryloxycarbonyl
(NVOC) or (α-methyl-2-nitropiperonyl)oxycarbonyl (MeN-
POC). As demonstration of the technology, an endogenous
opioid pentapeptide, leucine enkephalin YGGFL, and its
sequence variations were synthesized with eight different
PLPG-amino acids incorporated [6]. Although promising for
high-density peptide chips, this process has practical lim-
itations: photomasks are expensive and time consuming to
produce and the operation requires expensive equipment and
a high grade clean room environment; the preparation of
Figure 1. 1A. (left) Example of a conventional t-butyloxycarbonyl
(t-Boc) protected amino acid and (right) a photo-labile pro-
tecting group (PLPG) protected amino acid. Here PLPG is
(a-methyl-2-nitropiperonyl)oxycarbonyl (MeNPOC). 1B and 1C.
Illustration of the process of light-directed in situ synthesis of peptide chips
using 1B. photo-labile protected amino acids. Two key components are
required: the microfabricated photo-mask and PLPC amino acids for each
cycle of synthesis; and 1C. PGR chemistry and digital photolithography,
requiring conventional amino acids.
Figure 2. Reaction of PGA formation from triarylsulfonium hexa-
fluoroantimonate. Other products include reduced aromatic compounds and
phenylthioether compounds. PGA subsequently deprotects DMT as alcohol
protecting group to release an active OH group.
the monomers containing PLPG is not a trivial task; and
the photochemistry used is less efficient than conventional
t-Boc or Fmoc chemistry [50]. These shortcomings cause
poor synthesis and low sequence fidelity [52–54], rendering
the method too difficult to be used in a regular laboratory
setting and too costly to afford.
The reactions using photogenerated reagents
Basic concept
Parallel synthesis of microarrays containing libraries of mo-
lecules has distinct advantages in miniaturization. A key step
in performing a large number of these reactions in parallel
in a small area, e.g. cm2, is being able to control at each
site the reaction occurring or not occurring, or referring as
gating of reactions. The incorporation of photo-labile group
protection of functional groups, such as OH or NH2, is a
way of gating, which involves light irradiation for removal
of the protecting group to allow subsequent reactions at
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these deprotected reaction sites [6]. However, these photo-
lytic reactions are not highly efficient, giving yield in low
nineties. This limits the quality of the compounds that can
be synthesized in multi-step syntheses. Another drawback is
the requirement for photo-labile group protected monomers,
which are not commercially available and their synthesis in
many cases is practically impossible.
A breakthrough development in parallel synthesis is to
control the reaction through the generation of reaction re-
agent [36]. The reactions as described below illustrate the
use of solution in situ photogenerated reagents (PGR) to
affect otherwise conventional reactions in a highly parallel
fashion. The basic concept of the PGR chemistry is that a
conventional chemical/biochemical reaction occurs between
at least one reactant (generically denoted as ‘A’) and at least
one reagent (generically denoted as ‘R’) intramolecularly
or intermolecularly to give at least one product as depicted
below:
A + R → A’ + R’
A group of compounds that undergo photolytic reactions to
produce R are photogenerated reagent precursors (PGR-Ps).
The PGR thus produced then functions the same as a re-
agent conventionally used in a chemical reaction, and thus
the reaction proceeds in an otherwise conventional way. The
overall PGR chemistry reaction is depicted below.
hv
(PGR-P) → R
A + R → A’ + R’
Although first proposed for using PGR-P to gate parallel
synthesis in solution [36], there are a large number of PGA-
P compounds available. These are cationic polymerization
initiators or initiators of chemical amplification in photores-
ist processing of microelectronic devices [55–58]. These
reactions occur within a thin film of polymer, in the pres-
ence of high concentrations of photo-acid generator and acid
amplifiers. Photo-acid generator produces protic acid upon
light irradiation; acid amplifiers are organic proton donors,
sulfonate esters, and hindered acids, which undergo thermal
decomposition under acidic catalytic conditions to give pro-
tons. The chemical amplification reaction has been used to
remove the DMT (4,4’-dimethoxytrityl) group from the ter-
minal OH of immobilized oligonucleotides embedded in a
polymer coating in the synthesis of oligothymine sequences
[59]. Novel applications of acid amplification also include a
recent report on a silver-free, single-sheet imaging process,
producing color images suitable for printing applications
[60]. PGR chemistry differs from chemical amplification
in that it does not require an amplifier and is applicable
to a variety of different regents regularly used in chemical
reactions, such as photogenerated bases (PGBs). However,
besides PGAs, only few PGR compounds are available for
general use. A limited few PGB precursor compounds ex-
ist, which fall into the structure family of photo-labile group
protected amines [61, 62].
Photogenerated acid deprotection of DMT protected OH
group
Novel solution PGR photochemistry was first reported for
the deprotection of 5’-O-DMT of nucleosides using photo-
generated acids (PGAs) and its application to the automated
oligodeoxyribonucleotide synthesis [36]. The reaction of
PGA formation and its subsequent deprotection of a protec-
ted alcohol molecule are shown in Figure 2. It was shown
that protic PGA can be generated from a diazoketone sulf-
onate, sulfonium or iodium salts in an organic solution, such
as dichloride methylene (DCM). The PGA solution at tens of
mM concentration can effectively remove the DMT group to
free the 5’-OH group of nucleosides or nucleotides as seen
from HPLC profiles of the reactions, such as in deprotec-
tion of 5’-ODMT deoxynucleosides [36]. Oligonucleotides
were synthesized at reasonable quality on CPG (Controlled
Porous Glass) using PGA as deprotecting reagent. Recently,
precursor for formation of photogenerated trichloroacetic
acid (TCA) from 2-nitrobenzyl-trichloroacetate was repor-
ted to be used for oligonucleotide synthesis on a µmol scale
[63]. The DMT deprotection reaction using PGA on a chip
surface under optimal conditions requires only a few seconds
and will be described in a separate review article [64].
Photogenerated acid deprotection of t-boc protected NH2
group
The chemical principle of PGA reactions was extended to
the deprotection reaction of the t-Boc group of amino acids
[38]. Amino acids, such as Boc-Tyr(Bzl)-O- on HMBA-
AM resin, were reacted with a sulfonium antimonate or an
iodium antimonate at tens of mM concentration and in the
presence of thioxanthone as sensitizer in DCM to give depro-
tected NH2-Tyr(Bzl)-OH as the clean product, as examined
by reverse phase HPLC. The PGA reactions were also per-
formed on glass plates using fluorescein (FR) to monitor the
deprotection results. High efficiency of deprotection would
give higher reading of fluorescence, assuming the coupling
efficiency of FR is proportional to the degree of deprotection
by PGA. These results are of particular importance, since
they opened up the possibilities of incorporation of hun-
dreds of synthetic building blocks of amino acid analogs and
provide a basis for combinatorial synthesis of individually
addressable libraries of peptidomimetics on a microarray
platform. The t-Boc deprotection reaction using PGA on a
chip surface under optimal conditions requires much shorter
time, i.e. 2–4 min, compared to conventional deprotec-
tion using trifluoroacetic acid (TFA, 10–15 min), and this
shortening in reaction time is important for efficient parallel
synthesis of peptide microarrays.
Photogenerated reagents
In a more general scheme, the deprotection of DMT or
t-Boc group releases OH or NH2 group to allow sub-
sequently formation of phosphite triester or amide bonds.
It is highly desirable that the PGR chemistry can find
applications in other general types of organic reactions.
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Figure 6. Illustration of a conceptual biological system containing five major categories of components which modulate each other’s formation, disappearance,
and activities. The rate of formation of each species, such as R(mRNA) andR(protein) for molecule I, should be derived from a complex multiple component
equation. The expression equation for the overall system will require parameters known for all steps. At present, only stable mRNA can be measured for their
relative copies. There is a need for methods of measuring the presence of other types of molecules.
Figure 3. Illustration of combinatorial synthesis using the digital photo-
lithographic approach. (a) Peptide microarray to be synthesized; (b) com-
puter processing of the sequences; (c) light irradiation patterns generated
according the peptide sequences to be synthesized; (d) and (e) light
irradiation through a digital optical projection unit.
Figure 4. Illustration of some of the defects in in situ fluorescent monitor-
ing of synthesis quality on chip.
This in turn depends on the availability of diverse PGR
reagents. Thus, new PGR reagents, such as a pre-
cursor for photogeneration of piperdine or hydrazine (2-
(2-nitrophenyl)propoxycarbonyl piperidine (NPPOC-pip)
or 2-(2-nitrophenyl)propoxycarbonyl hydrazine (NPPOC-
Hz)) have been demonstrated and used in deprotection
of fmoc-amino group and Lys side chain (i.e. removal
of 4,4-dimethyl-2,6-dioxocyclohexylidene-)3-methyl-butyl,
ivDde), respectively [62].
Figure 5. Peptide chip synthesized using PGA chemistry and digital photo-
lithography for p53 antibody PAb240 (FR-labeled) epitope screening. The
consensus sequence is RHSVV. X represents one of 20 amino acids. Line
#4 validates the incorporation of 20 amino acids since coupling failure fol-
lowed by capping would terminate the binding. Lines #7 and #8 validate the
effective capping step, which terminates the synthesis and thus no binding
was observed.
Nonlinear reaction correlations in PGA induced
deprotection reactions
The PGA deprotection reactions studied on microchips
follow a nonlinear relationship between light irradiation
strength (i.e., the product of light intensity and irradiation
time) and the reaction efficiency (Figure 2 in ref. [25] and
Figure 4 in ref. [39]). In these experiments, light irradiation
at different sites applies increasing or decreasing intensities
or time (0–100% gray scale irradiation). After deprotection
by PGA, FR was coupled to the reaction site and the resultant
fluorescent signals were plotted as a function of light con-
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ditions to give sigmoid curves. The nonlinear relationship
shown is consistent with a possible general acid catalyzed
reaction mechanism for removal of the t-Boc group from an
amino group or the DMT group from a hydroxyl group. This
correlation is preferred for minimal unwanted deprotection
due to stray light [65] or acid diffusion, ensuring high qual-
ity synthesis. In contrast, photolytic reactions such as the
cleavage of PLPG follows an undesirable linear relationship
with the light intensity used [65].
Digital photolithography and combinatorial synthesis
A significant improvement in making photolithography a
practical method for combinatorial chemical synthesis has
been to introduce the use of a digital optical unit for light pat-
tern projection onto the surface of a reaction device (Figure
3) [25, 36, 39, 66–68]. Light irradiation with selective pat-
terns results in selectively photoactivating a reaction at cer-
tain sites, and thus permits parallel synthesis for the prepar-
ation of a large number of different molecules on the same
reaction surface. For synthesis of biopolymers, such as oli-
gonucleotides and peptides, this automated method provides
greater flexibility since microarrays containing any desirable
sequences can be obtained quickly through a computer con-
trolled process (Figure 3). Specifically, a digital optical unit
consists of a light source capable of generating enough en-
ergy for chemical reactions and a programmable light pattern
formation and projection device conducting light irradiation.
Texas Instruments’ Digital Micromirror Device (DMDTM)
based on the Digital Light Processing (DLPTM) technology
[69] was first used for these applications. Light patterns can
also be generated using a programmable laser source [41].
PGR chemistry is particularly suited for use in combin-
ation with digital photolithography for creation of micro-
arrays [36]. To explore the best reaction conditions for
microchip synthesis, such as the choice of PGA precursors,
solvents, reaction time, light irradiation time or intensities,
different PGR or PGA generation conditions can be screened
in hours directly on the combinatorial synthesis platform
[38]. For example, as shown in Figure 4, the chip syn-
thesis begins with filling all reaction sites derivatized with
t-Boc amino linker molecules with a PGA precursor solu-
tion; irradiating surface with a first light pattern to induce
photolytic reactions in the first set of reaction sites; removal
of the t-Boc group at these irradiated sites exposes a free
NH2 group. The second cycle of the synthesis uses a second
set of reaction conditions; the irradiation uses a second light
pattern to cause removal of the t-Boc group and formation of
a free NH2 group at a second set of selected reaction sites.
The reactions are repeated multiple times for all reaction
conditions to be tested. At the end of the reaction, the sur-
face contains reaction sites in which the completion of the
deprotection reactions is different due to different reaction
conditions applied. The best reaction conditions should cor-
relate with the efficient formation of the NH2 groups each
time the t-Boc group is removed. The last step of the chip
synthesis is to couple with FR; the number of FR molecules
coupled to the surface is proportional to the number of NH2
groups. Therefore, the detection of the fluorescence intensity
directly correlates with the efficiency of reaction conditions.
This method allowed a quick search of optimal PGA con-
ditions for oligonucleotide and peptide chip synthesis, and
is applicable to the synthesis of microchips containing other
types of molecules. The FR in situ assays are also used to
optimize coupling and capping steps. As mentioned above,
regular peptide synthesis requires about 2 hr per addition
of monomer, but better reaction conditions for parallel syn-
thesis found through optimization of t-Boc deprotection now
require about 20 min [25], which is 6-fold reduction in reac-
tion time per cycle, making it feasible to synthesize peptide
microarrays of shorter sequences with molecular diversity in
a matter of hours.
It is important to point out that the aforementioned in situ
FR assays as a means of monitoring synthesis should be used
with caution. This is because the reporter FR groups only
reflect the total presence of the functional groups without re-
lating to their history of formation [37]. Residual functional
groups due to failed coupling and capping also contribute to
coupling of FR. While it is a semi-quantitative comparison,
the FR signal reading should be validated by cleavage of
the synthesized sequences and their subsequent assays [37].
More careful design of an on-chip assay, such as inserting
a repetitive step of coupling and then comparing the differ-
ence in the final FR signal readings, may help to reduce the
influence of the artifacts in final fluorescence readings.
Peptide chip synthesis using PGA chemistry
The general synthesis of peptide chips using t-Boc chem-
istry involves steps of light controlled deprotection by PGA,
coupling with a t-Boc protected amino acid, and capping
(Figures 1C and 4). This is further illustrated using an ex-
ample of the synthesis of peptide chips for p53 antibody
PAb240 epitope screening based on the consensus sequence,
RHSVV [25, 70, 71] Multiple subsets of peptides were
designed and their sequences were compiled into a pseudo-
sequence, which was used to direct the steps of amino acid
addition by the synthesizer. At each synthesis cycle, a PGA
solution was applied to the chip surface at the deprotection
step; light irradiation from the digital optics unit at specific
reaction sites was applied for duration of 2–4 min. The chip
was then washed with solvent and subsequently allowed to
react with an N-t-Boc protected amino acid. The amino acid
coupled to where light irradiated and the unreacted reaction
sites were capped with acetyl group. The final step was
FR coupling and the fluorescent image was scanned after
side chain deprotection. In the example shown in Figure 5,
the combinatorial steps are at those positions marked with
X, which represents the incorporation of natural 20 amino
acids, eight synthetic peptidomimetics compounds, or acet-
ylation, while the rest of the synthesis steps used a single
amino acid. This was to freeze the sequence in all posi-
183
tions except one in order to identify sequence specificity
associated with a particular position in a peptide sequence.
The incorporation of all 20 natural amino acids was valid-
ated by the presence of fluorescent signals from the series
of RHSVVX (X = one of the 20 amino acids) sequences.
For this set of spots, if the synthesis of X failed, the site
should be capped and the fluorescence tagging or the binding
should not be observed. To test whether racemization oc-
curred during synthesis, sequences containing the D-isomers
of Ser and Val were synthesized. These sequences did not
show binding to PAb240 antibody, providing evidence that
racemization at Cα is negligible.
Peptide chip experimental design
Synthesis of peptide chips is challenging in its chemical re-
quirement and experimental design for simultaneous large
scale reactions. A synthesis without proper consideration
of the chip design will not generate the results as hoped.
In addition to have a clear goal prior to chip synthesis, no
matter how perfectly a synthesis or an assay will be per-
formed, there are always experimentally introduced errors
and imperfection in chip results. Therefore, it is critical to
incorporate on-chip controls and references to compensate
for experimental errors and to establish bases for background
correction and normalization of signal intensities. Although
the chip designs depend on the type of chips, it is useful to
pay attention to the follow points: (a) dividing a large data
set into small subsets consisting of data points which contain
systematic variations of one or few parameters and are easily
compared; (b) replicating data points within a chip at differ-
ent locations; (c) using a constant set of controls for in situ
monitoring in synthesis and assays in each subset of data per
chip; (d) incorporating background controls (no synthesis),
known positive and negative controls at constant locations.
Applications of peptide chips
The following discussion is intended not to repeat top-
ics covered by this special edition of protein and peptide
microarray technologies, but to discuss a few examples rep-
resentative of recent development of peptide microarrays as
demonstration of the applications of high density peptide
chips. There are also a number of comprehensive reviews
of various peptide microarrays, their synthesis, fabrication,
and applications [26–31, 33, 34, 42].
A brief overall review
Peptide microarrays have found important, diverse applica-
tions (Scheme 1). Peptide microarrays complement phage
display well for discovery of binding sequences for pro-
tein profiling and studies of protein functions. Phage display
[42–45] may represent a huge population of up to 1015 se-
quences, but its selection bias exists because only natural
amino acids or certain types of amino acids and the related
sequences are preferably expressed. Peptide microarrays
usually contain hundreds to thousands of sequences, having
residue-specific sequence definition and a large library of
synthetic analogs of amino acids that can be incorporated
into the synthesis. There have been hundreds of examples
of SPOT synthesized peptide microarrays utilized for map-
ping binding sites and functional studies in proteins or other
host molecules of biological and therapeutic importance as
reviewed in this edition of the journal and literature [5, 31,
32]. Further, the combined use of phage display and pep-
tide microarray through protein/peptide-peptide interactions
has been successfully used for identification of unknown
proteins [72, 73]; these selected target proteins may be fur-
ther enriched and identified through hybridization of the
phage sequences to a DNA microarray [34]. Another type
of application of peptide microarrays is its combined use
with combinatorial synthesis [33]. Novel applications for
screening of inhibitors of protein kinases and peptide lig-
ands for cell surface receptors have shown great promise in
extending of peptide microarray applications from probing
protein-protein interactions to cell signaling pathways and
other high level complex interactions in biological systems.
Low density peptide microarrays by spotting and using im-
proved linker chemistry on gold-surface have been demon-
strated for surface plasmon resonance (SPR) or SPR imaging
measurements [26, 74]. In affinity tag screening [74], bind-
ing constants of the flag affinity peptides to its antibodies
were obtained directly from SPR intensities. In the stud-
ies of kinase protein-substrate interactions, three types of
measurements were demonstrated: SPR, fluorescence, and
phosphorimaging, allowing activity assay and quantitative
measurements for the inhibition of the enzymatic phos-
phorylation reactions [26]. Recently, a peptide microarray
containing Pb(II) ion specific peptides has shown promising
as a biosensor for metal ion detection [41].
High density peptide chips used in binding assays
High density peptide chips containing thousands or more
features per cm2 area are of tremendous potential for high
throughput, automated binding and functional assays. The
first example of epitope binding to an antibody using Y/P-
GGFL pentapeptide chips made from eight different photo-
labile group protected monomers was demonstrated more
than a decade ago [6]. The binding of YGGFL to anti-β-
endorphin antibody (mAb 3E7) was detected using a FR
labeled IgG secondary antibody. This photolithographic par-
allel synthesis method was also applied to the synthesis of
biopolymers consisting of carbamade backbone from photo-
labile protected aminocarbonate monomers. High affinity
binding was detected between the specific sequences and
a carbamate specific antibody conjugated with FR [35].
Clearly, further development of these peptide chips using
the prescribed approach [6, 35] is not feasible due to the
requirement of at least 20 photo-labile protected monomers
and less than satisfactory photolytic deprotection reactions.
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Epitope screening using p53 antibodies
Recent development of the PGA chemistry for microarray
synthesis has led to several reports on the applications of
peptide chips, especially high density peptide chips, to
epitope screening [25, 40, 41]. Peptide chips containing epi-
tope sequences from tumor suppressor p53 and the related
truncation, permutation, and amino acid analog modified
sequences were constructed (vide supra). The p53 peptides
are epitopes (residues 20–25 or 213–217) to antibody mAb
DO1 (SDLHKL) [41] or PAb240 (RSHVV) [25], respect-
ively. The binding to these antibodies has been used to detect
p53 mutations or identify p53-like proteins. The binding to
Pab240 used 0.04 µg of fluorescent dye labeled antibody
in 40 µL solution and discrimination in binding specificity
among the peptides was clearly detected. A representative
image of p53 peptide chip binding to PAb240 is shown in
Figure 5. From the point of view of practical applications,
the photolithography based synthesis produces peptide chips
of high spot uniformity and their data are easy to process due
to regularly distributed spots in rows and columns. There-
fore the binding data can be analyzed and the information
can be obtained quickly. The p53 peptide chip binding stud-
ies relied on several hundreds of sequences of peptides and
peptidomimetics incorporating 20 natural amino acids, D-
isomers, and synthetic analogs of amino acids. These chips
were made in replicates in a square cm area; these results
unambiguously confirmed the RHSVV epitope sequence
identified previously by phage display [70, 71] and found
new peptidomimetic antibody recognition elements, such as
RHS(Abu)(Abu/Nva/Nle) (2-aminobutyric acid, norvaline,
norleucine) with moderate binding affinity to PAb240. These
systematic variations of the sequence designs on peptide
chips also permitted a better understanding of the specificity
and selectivity of the epitope binding site of the antibody
[25].
Affinity tag screening using antiflag antibody M2
Recently, there has been a rapidly increasing effort in large
scale studies of proteome proteins [75–78]. Proteins are usu-
ally amplified in an expression system with fusion affinity
tag and purified using affinity columns. Thus, as simultan-
eous protein expression and purification become necessary
steps for achieving such large scale studies, the needs also
increase for improved affinity tags and a larger pool selec-
tion of affinity sequences. High density peptide chips have
been used to characterize the binding profile and map bet-
ter binding sequences based on Flag peptide DYKDDDDK
to anti-Flag antibody M2 (AFM2) [40]. The studies were
divided into several subsets including those systematically
mutating (10 amino acid variation at the first three positions
of the sequence) and truncating (dimer to octamers) and a
series of repeat sequences. After the initial binding assays,
DYK and DYKDDDDK were found to have comparable
binding and used as the positive controls and DYA as the
negative controls. In each subset of designs on chip, the
control sequences were included, making possible baseline
subtraction, normalization and cross comparing the results
from multiple subsets within and among chips. The results of
these studies revealed selective dimers and trimers possible
as AFM2 binding motifs and a number of stronger AFM2
affinity sequences compared to the original DYKDDDDK
[40]. The high affinity binding to AFM2 by the repeating
sequences was confirmed by on bead binding of the same
set of sequences. In general, shorter sequences should be
more selective in specific antibody binding but it remains to
be seen if shorter sequences will provide sufficient binding
affinity when incorporated into large proteins. The availabil-
ity of these affinity peptides, nonetheless, provides possible
choices for better matching of the fusion affinity tags and
proteins. The finding of a number of high affinity sequences
to AFM2 reveals possible undesirable cross-interactions of
the N- or C-terminal of proteins to the affinity antibody,
interfering with intended protein purification and analysis.
There will be similar experiments performed for screening
high affinity tags of different sequences specific to different
antibodies.
Concluding Remarks
The growing interests in the studies on genomic or proteo-
mic scales present unprecedented opportunities and daunting
tasks. A clear trend is already in place to conduct experi-
ments in a parallel fashion and down-sizing formats, which
allow faster throughput, easy comparison of experimental
results, and automation. In a way similar to the process of
five decades for the improvement and adaptation of com-
puters, we will see continuing shift in bio- and chemical
technologies to miniaturization, system integration, paral-
lelization, and automation. As discussed in this review,
peptide chips have the promise as a key component for a
miniaturized system that will allow not only synthesis, but
also sample processing and interrogation and extrapolating
information on genomic and proteomic scales.
This review emphasizes a technology platform of bio-
chip synthesis and applications [25, 36–41]. The basis of
the technology consists of three key components: (a) photo-
generation of reagents for triggering conventional chemical
reactions upon light irradiation, (b) digital photolithography,
and (c) microchip for reactions in isolated sites. The combin-
ation of these elements creates a highly flexible, simple, ef-
ficient, low cost process for synthesis of peptide chips based
on conventional peptide chemistry. Although still in an early
stage, the peptide chips produced have been successfully
used for rapid screening of specific binding sequences us-
ing epitope specific monoclonal antibodies. Peptide chips
allow an important strategy for the effective use of a large
number of data points, i.e., to systematically vary the se-
quences in a subset of data. By incorporating within each
subset of data proper control sequences at multiple, desig-
nated positions on chip, rich information can be obtained
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in a more reliable manner. Thus, the power of peptide chip
applications is in massively parallel comparisons of the test
points; quantitative analysis of absolute values is more chal-
lenging and still awaiting for method development [26, 74].
The advance in synthesis methods and instrument integra-
tion will explore the potential of peptide chips by increasing
chemical structural diversity to peptide conjugates with car-
bohydrates, small molecules, nucleotides, and other types
of molecules. These molecular chips will expand the ap-
plications from probing protein-substrate interactions and
binding screening to screening of drug molecules of diverse
structures [79] and receptor-substrate interactions. Biochips
should be promising not only as powerful research tools
but as a new generation of diagnostic devices that will ac-
company increasingly computer managed personal medical
care.
The development of DNA chips, peptide chips, pro-
tein and antibody chips, and potentially many other types
of biochips should pave the way to understanding systems
biology. In this regard, we are still at the infancy of the
development processes. In Figure 6 a conceptual network
of a self-regulating biological system is shown. Presently,
DNA chips, when sampled properly, allow a snapshot of
the presence of stable mRNA. But our capability is very
limited in detection and measurement of proteins and pro-
tein modifications, leaving many parameters in system’s
biological processes unknown. It is not surprising that the
correlations of mRNA expression with protein expression
are often non-existent. However, by investing intensive ef-
fort in high throughput parallel analysis of nucleic acids
and proteins on a global scale, we are now more hopeful
than ever to extrapolate the various parameters controlling
the multiple stages of biological processes and to even-
tually understand the circuitry of the entire operation. In
this process, in situ synthesized peptide and peptidomimetic
microarrays will continue play an important role for detec-
tion and quantitation of proteins, identification of therapeutic
protein/receptor targets, discovery of drug candidates, and
many other applications.
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